We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Eagle argued in favor of broad exclusivity for its product, writing that it should apply to any applications containing bendamustine for the indications protected by the orphan exclusivity. Read More
The expert panel also issued a positive opinion for Bevespi Aerosphere, AstraZeneca’s maintenance treatment for chronic obstructive pulmonary disease. Read More
The state of Kentucky has filed a lawsuit against Teva, alleging the drugmaker’s off-label promotion of two drugs for cancer pain has exacerbated the opioid epidemic. Read More
Abbott Laboratories and AbbVie reached a $25 million settlement with the federal government, which charged the companies violated the False Claims Act to promote sales of the drug TriCor (fenofibrate). Read More
Arkansas Attorney General Leslie Rutledge petitioned the Supreme Court to uphold a state law that requires PBMs to reimburse pharmacies after they dispense drugs to patients at wholesale inventory costs. Read More